Provided by Tiger Trade Technology Pte. Ltd.

Pharming Group N.V.

11.46
-0.3900-3.29%
Post-market: 11.470.0100+0.09%16:10 EDT
Volume:23.17K
Turnover:268.53K
Market Cap:809.37M
PE:90.56
High:12.21
Open:11.62
Low:11.45
Close:11.85
52wk High:21.34
52wk Low:9.62
Shares:70.63M
Float Shares:69.50M
Volume Ratio:1.35
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1266
EPS(LYR):0.0400
ROE:3.65%
ROA:3.47%
PB:2.99
PE(LYR):286.50

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Pharming Launches Joenja in Japan for Adult, Pediatric APDS Patients

MT Newswires Live
·
Aug 13

Pharming Group is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Aug 04

Analysts Conflicted on These Healthcare Names: Bausch + Lomb Corporation (BLCO) and Pharming Group (PHAR)

TIPRANKS
·
Jul 31

Pharming Group's Q2 Earnings, Revenue Fall; 2026 Revenue Outlook Updated

MT Newswires Live
·
Jul 30

Pharming Group NV Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Pharming Q2 EPS $0.02, Inline, Sales $90.200M Miss $100.625M Estimate

Benzinga Earnings
·
Jul 30

Press Release: Pharming Reports Second Quarter and First Half 2026 Financial Results and Revises Year-end Guidance; Strong Joenja Momentum and Near-term Clinical Readouts to Support Broader Therapeutic Use

Dow Jones
·
Jul 30

Pharming Group NV Expected to Post Earnings of 2 Cents a Share - Earnings Preview

Reuters
·
Jul 28

Pharming Group Says Marketing Application for Immunodeficiency Disorder Drug Accepted by FDA

MT Newswires Live
·
Jun 04

Pharming Says European Commission Grants Marketing Authorization to Joenja

MT Newswires Live
·
May 23

Pharming’s Joenja granted marketing authorization by European Commission

TIPRANKS
·
May 23

Pharming Group (PHAR) Gets a Buy from Canaccord Genuity

TIPRANKS
·
May 09

ADRs End Lower; Pharming Group N.V. Declines 27%

Dow Jones
·
May 08

Stock Track | Pharming Group Plunges 17.32% in Pre-Market After Q1 Earnings and Revenue Miss Estimates

Stock Track
·
May 07

Stock Track | Pharming Group Plunges 11.95% in Pre-market After Q1 Earnings Miss Estimates

Stock Track
·
May 07

Pharming Group NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Pharming Q1 EPS $(0.07) Misses $0.01 Estimate, Sales $72.400M Miss $93.750M Estimate

Benzinga Earnings
·
May 07

Press Release: Pharming Group reports first quarter 2026 financial results; on track for Joenja(R) U.S. pediatric label expansion and launches in Japan and Europe in 2026

Dow Jones
·
May 07

Pharming Group NV expected to post earnings of 1 cent a share - Earnings Preview

Reuters
·
May 05